Additionally, radiotherapy is used before or after surgery, and in the case of disseminated CRC, targeted therapy such as anti-epidermal growth factor receptor (anti-EGFR) antibodies and anti-vascular endothelial growth factor receptor antibodies (anti-VEGFR) is used [6,7]. The gene discussed is EGFR; the disease is colorectal carcinoma.